Identification, Antioxidant and Immunomodulatory Activities of a Neutral Exopolysaccharide from

Yanyan Huang, Weiting Liang, Yunhui Lu, Jie Xiong, Dongmei Liu, Xiangze Jia

Abstract read

In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Gut-Protective and Multifunctional Exopolysaccharide fromNutrients · 2025
Article
Iranian journal of veterinary research · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanyan HuangGuangdong Provincial Key Laboratory of Intelligent Food Manufacturing, College of Food Science and Engineering, Foshan University, Foshan 528225, China.ORCID 0000-0003-4136-6044

Weiting LiangGuangdong Provincial Key Laboratory of Intelligent Food Manufacturing, College of Food Science and Engineering, Foshan University, Foshan 528225, China.

Yunhui LuGuangdong Provincial Key Laboratory of Intelligent Food Manufacturing, College of Food Science and Engineering, Foshan University, Foshan 528225, China.

Jie XiongSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.ORCID 0000-0001-7938-0402

Dongmei LiuSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.

Xiangze JiaSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.ORCID 0009-0004-4248-352X

Funding

Guangdong Provincial Key Research and Development Program 2023B0202040002the Key Laboratory Project of Guangdong Province 2022B1212010015

6 · The paper itself

Abstract

objectivesThis study investigated the properties of a neutral exopolysaccharide (EPS-LP1) with an average molecular weight of 55,637 Da, isolated from

resultsThe composition of EPS-LP1 includes galactose (Gal), glucose (Glu) and mannose (Man) in a molar ratio of 5.35:86.25:8.40. Notably, EPS-LP1 exhibits a smooth and rod-like surface along with thermal stability. Methylation combined with nuclear magnetic resonance analysis revealed that EPS-LP1 structured as t-Gal

conclusionsThis research provides a foundation basis for further investigations into the neutral exopolysaccharide derived from LP9010.

Indexed as

AntioxidantsImmunologic FactorsPolysaccharides, BacterialAnimalsMacrophagesMiceNitric OxideOxidative StressRAW 264.7 CellsReactive Oxygen SpeciesAntioxidantsImmunologic FactorsNitric OxidePolysaccharides, BacterialReactive Oxygen Speciesantioxidant activityextracellular polysaccharideimmunoregulatory activityLactiplantibacillus plantarum DMDL 9010structural characterization

Identifiers

PMID40732890

DOI10.3390/nu17142265

PMCPMC12298170

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.